FIELD: medicine.
SUBSTANCE: invention relates to the use of oxyethylammonium methylphenoxyacetate in combination for the production of a medicinal product having adaptogenic, immunomodulatory and antiviral activity against influenza A, influenza B, parainfluenza viruses and seasonal coronavirus OS43. The following is proposed: the use of oxyethylammonium methylphenoxyacetate in combination with o-cresol, and/or 2-phenoxyacetic acid, and/or 2-(3-methylphenoxy) acetic acid, and/or 2-(4-methylphenoxy) acetic acid or a mixture of these substances and calcium, and/or phosphorus, and/or zinc or a mixture of elements taken in the following ratio of components, wt.%: oxyethylammonium methylphenoxyacetate 20–60, o-cresol 0.00001–0.5, and/or 2-phenoxyacetic acid, and/ or 2-(3-methylphenoxy) acetic acid, and/or 2-(4-methylphenoxy) acetic acid or a mixture of these substances 0.00001–0.5, phosphorus 0.00001–0.29 and/or zinc 0.0000001–0.00050 or a mixture thereof, microcrystalline cellulose, lactose monohydrate, sodium stearyl fumarate, calcium stearate, aerosil, potato starch or mixtures thereof up to 100 for the production of a medicinal product having adaptogenic, immunomodulatory and antiviral activity against influenza A, influenza B viruses, parainfluenza and seasonal coronavirus OS43.
EFFECT: above invention makes it possible to obtain a medicinal product of hydroxyethylammonium methylphenoxyacetate with increased adaptogenic, immunomodulatory and antiviral effects, increased bioavailability and reduced adverse reactions.
1 cl, 4 dwg, 15 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ADAPTOGENIC, IMMUNOMODULATING AND ANTI-VIRAL PHARMACEUTICAL COMPOSITION OF OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2023 |
|
RU2806534C1 |
PHARMACEUTICAL COMPOSITION OF OXY-ETHYLAMMONIUM METHYLPHENOXYACETATE | 2020 |
|
RU2762552C2 |
LIQUID PHARMACEUTICAL COMPOSITION OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2021 |
|
RU2783660C2 |
TOOL THAT IMPROVES THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 2ND DEGREE OBESITY | 2021 |
|
RU2769519C1 |
IL-12 AND IL-1A INDUCER | 2014 |
|
RU2564114C1 |
TOOL IMPROVING THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 1ST DEGREE OBESITY | 2021 |
|
RU2761618C1 |
WATER-SOLUBLE SULPHONATED POLYMERS WITH INTRINSIC ANTIVIRAL ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2814298C1 |
MEANS TO IMPROVE THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 1 DEGREE OBESITY | 2021 |
|
RU2775178C1 |
METHOD FOR PRODUCING PROPHYLACTIC ANTIVIRAL COMPOSITION BASED ON EPIGALLOCATECHIN-3-GALLATE (EGCG) | 2021 |
|
RU2771898C1 |
MEANS THAT IMPROVES THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 2 DEGREE OBESITY | 2021 |
|
RU2775179C1 |
Authors
Dates
2023-11-02—Published
2023-04-07—Filed